Cargando…
Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
Multiple myeloma (MM) remains to be an incurable disease. The purpose of this study was to evaluate the effect of ABCG2 monoclonal antibody (McAb) combined with paclitaxel (PTX) conjugated with Fe(3)O(4) nanoparticles (NPs) on MM progressed from cancer stem cells (CSCs)in non-obese-diabetic/severe-c...
Autores principales: | Yang, Cuiping, Xiong, Fei, Dou, Jun, Xue, Jun, Zhan, Xi, Shi, Fangfang, Li, Miao, Wu, Songyan, Luo, Shouhua, Zhang, Tianzhu, Zhang, Yu, Ming, Ji, Gu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695020/ https://www.ncbi.nlm.nih.gov/pubmed/26314844 |
Ejemplares similares
-
Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles
por: Shi, Fangfang, et al.
Publicado: (2018) -
Paclitaxel-Fe(3)O(4) nanoparticles inhibit growth of CD138(−) CD34(−) tumor stem-like cells in multiple myeloma-bearing mice
por: Yang, Cuiping, et al.
Publicado: (2013) -
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo
por: Duan, Xiao-Chuan, et al.
Publicado: (2018) -
A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles
por: Cui, Fei, et al.
Publicado: (2013) -
Hsa_Circ_0007841 Enhances Multiple Myeloma Chemotherapy Resistance
Through Upregulating ABCG2
por: Song, Yan, et al.
Publicado: (2020)